Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

396.22
Delayed Data
As of May 27
 +2.68 / +0.68%
Today’s Change
348.96
Today|||52-Week Range
605.93
-27.01%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
AssetsCash390.6M654.6M809.1M604.2M
 
 
 
 
 
Short Term Investment Cash-117.4M264.0M154.5M-204.9M
 
 
 
 
 
Cash & Short Term Investments604.2M895.6M1.0B849.2M
 
 
 
 
 
 
ReceivablesReceivables1.4B1.4B1.5B1.9B
 
 
 
 
 
 
InventoriesInventories171.3M190.7M238.6M303.3M
 
 
 
 
 
 
Current AssetsOther Current Assets112.7M150.0M163.5M115.7M
 
 
 
 
 
Current Assets2.3B2.7B2.9B3.1B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross----1.9B--
 
 
Depreciation-----331.1M--
 
 
Other Assets4.1M4.6M5.8M5.8M
 
 
 
 
 
Total Assets4.5B5.2B5.6B5.9B
 
 
 
 
 
 
LiabilitiesAccounts Payable130.0M106.9M141.0M120.6M
 
 
 
 
 
Accrued Expenses316.4M349.6M369.9M375.9M
 
 
 
 
 
Other Current Liabilities388.4M507.1M537.0M562.4M
 
 
 
 
 
Other Liabilities601.5M735.0M811.2M919.7M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt388.0M394.9M362.9M362.2M
 
 
 
 
 
Deferred Taxes-323.8M-346.2M-461.9M-543.7M
 
 
 
 
 
Other Liabilities76.1M77.9M115.5M121.0M
 
 
 
 
 
Total Liabilities1.2B1.9B2.0B2.1B
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity3.3B3.3B3.7B3.8B
 
 
 
 
 
Total Shareholder Equity3.3B3.3B3.7B3.8B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding103.6M104.1M104.6M105.0M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.